SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?

To: Eric P who wrote (714)1/28/1999 6:01:00 PM
From: DEER HUNTER  Read Replies (1) | Respond to of 1906
 
Eric....you said "Apparently, the earnings report and stock split did not impress the analysts or institutions. After closing at 119 9/16, the stock traded after hours up to only 124, before backtracking down to 122".

How do you know this report did not impress the analysts or institutions? The fact is this stock traded at an all time high today....AMGN must be impressing someone. A lot of someones.

DH



To: Eric P who wrote (714)1/29/1999 10:27:00 AM
From: JGoren  Read Replies (1) | Respond to of 1906
 
Admit it; you were way off in your prediction of how the stock would act today. Amgen is a long-term holding. Not a daytrader's stock.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News